Ftse Mib
37.582,05
0,91%
DAX
22.037,83
0,48%
S&P 500
6.068,50
0,03%
NASDAQ
19.643,86
-0,36%
Bitcoin
95.856,50
0,11%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE West Pharmaceutical Services Inc (WST) West Pharmaceutical Services Inc (WST) Notizie

West Pharmaceutical Services Inc

WST
322,40
-1,73 (-0,53%)
12 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
30/1/202512:00PRNUSWest to Host Fourth-Quarter and Full-Year 2024 Conference..
28/1/202518:00PRNUSWest Announces First-Quarter Dividend
22/1/202512:00PRNUSWest Introduces Daikyo PLASCAP® RUV Closures in New Nested..
17/1/202519:27EDGAR2Form 3/A - Initial statement of beneficial ownership of..
06/1/202522:30PRNUSWest Pharmaceutical Services to Present at the CJS 25th..
19/12/202400:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202422:02EDGAR2Form 8-K - Current report
11/12/202422:11EDGAR2Form 8-K - Current report
11/12/202412:00PRNUSWest Elects New Director to the Board
31/10/202417:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202416:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/10/202411:00PRNUSWest to Participate in Upcoming Investor Conferences
24/10/202422:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
24/10/202413:50EDGAR2Form 8-K - Current report
24/10/202412:00PRNUSWest Announces Third-Quarter 2024 Results, Increases Fiscal..
23/10/202422:57EDGAR2Form S-8 POS - Securities to be offered to employees in..
22/10/202412:00PRNUSWest to Present on Large Volume Delivery Systems,..
10/10/202412:00PRNUSWest to Host Third-Quarter 2024 Conference Call
09/10/202412:00PRNUSWest Wins Heart of Pharma Award at 2024 CPHI Pharma Awards
07/10/202412:00PRNUSWest to Attend and Showcase Industry Leadership in Packaging..
05/9/202412:00PRNUSWest to Participate in Upcoming Investor Conference
21/8/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202422:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202422:13EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
06/8/202422:47EDGAR2Form 144 - Report of proposed sale of securities
25/7/202422:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
25/7/202414:05EDGAR2Form 8-K - Current report
25/7/202412:00PRNUSWest Announces Second-Quarter 2024 Results
11/7/202412:00PRNUSWest to Host Second-Quarter 2024 Conference Call
08/7/202413:56EDGAR2Form 8-K - Current report
13/6/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202412:00PRNUSWest Introduces Daikyo Crystal Zenith® (CZ) Ready-to-Use..
28/5/202412:00PRNUSWest to Participate in Upcoming Investor Conference
22/5/202422:05EDGAR2Form SD - Specialized disclosure report
10/5/202419:35EDGAR2Form 144 - Report of proposed sale of securities
09/5/202421:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202421:39EDGAR2Form 144 - Report of proposed sale of securities
30/4/202412:00PRNUSWest to Participate in Upcoming Investor Conference
25/4/202412:00PRNUSWest Announces First-Quarter 2024 Results and Declares..
11/4/202412:00PRNUSWest to Host First-Quarter 2024 Conference Call
01/3/202422:24EDGAR2Form PRE 14A - Other preliminary proxy statements
01/3/202419:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202422:30PRNUSWest to Participate in Upcoming Investor Conferences
27/2/202422:23EDGAR2Form 144 - Report of proposed sale of securities
27/2/202417:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202400:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202400:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202400:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 321,43 Min: 320,30 Max: 325,20
Chiusura: 324,13

La tua Cronologia

NYSE
WST
West Pharmaceutical Serv...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci